Showing 621-640 of 8668 for: Cochrane Systematic Reviews Back
- Antidepressants for people with both schizophrenia and depression
Cochrane Systematic Reviews, 22-Apr-2002
Depressive symptoms, often of substantial severity, are found in 50% of newly diagnosed suffers of schizophrenia and 33% of people with chronic schizophrenia who have relapsed. Depression is associated with dysphoria, disability, reduction of motivation t
- Antidepressants for people with epilepsy and depression
Cochrane Systematic Reviews, 16-Apr-2021
Depressive disorders are the most common psychiatric comorbidity in people with epilepsy, affecting around one-third, with a significant negative impact on quality of life. There is concern that people may not be receiving appropriate treatment for their
- Antidepressants for polycystic ovary syndrome
Cochrane Systematic Reviews, 31-May-2013
The prevalence of depression in women with polycystic ovary syndrome (PCOS) is high; one study has shown it to be four times that of women without PCOS. Therefore, systematic evaluation of the effectiveness and safety of antidepressants for women with PCO
- Antidepressants for preventing postnatal depression
Cochrane Systematic Reviews, 18-Apr-2018
Depression is common in the postnatal period and can lead to adverse effects on the infant and wider family, in addition to the morbidity for the mother. It is not clear whether antidepressants are effective for the prevention of postnatal depression and
- Antidepressants for smoking cessation
Cochrane Systematic Reviews, 22-Apr-2020
Whilst the pharmacological profiles and mechanisms of antidepressants are varied, there are common reasons why they might help people to stop smoking tobacco. Firstly, nicotine withdrawal may produce depressive symptoms and antidepressants may relieve the
- Antidepressants for the negative symptoms of schizophrenia
Cochrane Systematic Reviews, 26-Apr-2012
Negative symptoms are common in people with schizophrenia and are often difficult to treat with antipsychotic drugs. Treatment often involves the use of various add-on medications such as antidepressants.
- Antidepressants for the treatment of depression in people with cancer
Cochrane Systematic Reviews, 23-Apr-2018
Major depression and other depressive conditions are common in people with cancer. These conditions are not easily detectable in clinical practice, due to the overlap between medical and psychiatric symptoms, as described by diagnostic manuals such as the
- Antidepressants for the treatment of people with co‐occurring depression and alcohol dependence
Cochrane Systematic Reviews, 24-Apr-2018
Alcohol dependence is a major public health problem characterized by recidivism, and medical and psychosocial complications. The co-occurrence of major depression in people entering treatment for alcohol dependence is common, and represents a risk factor
- Antidepressants for treating depression in adults with end‐stage kidney disease treated with dialysis
Cochrane Systematic Reviews, 23-May-2016
Depression affects approximately one-quarter of people treated with dialysis and is considered an important research uncertainty by patients and health professionals. Treatment for depression in dialysis patients may have different benefits and harms comp
- Antidepressants for treating depression in dementia
Cochrane Systematic Reviews, 31-Aug-2018
The use of antidepressants in dementia accompanied by depressive symptoms is widespread, but their clinical efficacy is uncertain. This review updates an earlier version, first published in 2002.
- Antidepressants plus benzodiazepines for adults with major depression
Cochrane Systematic Reviews, 3-Jun-2019
Anxiety frequently coexists with depression and adding benzodiazepines to antidepressant treatment is common practice to treat people with major depression. However, more evidence is needed to determine whether this combined treatment is more effective an
- Antidepressants versus placebo for depression in primary care
Cochrane Systematic Reviews, 8-Jul-2009
Concern has been expressed about the relevance of secondary care studies to primary care patients specifically about the effectiveness of antidepressant medication. There is a need to review the evidence of only those studies that have been conducted comp
- Antidepressants versus placebo for panic disorder in adults
Cochrane Systematic Reviews, 5-Apr-2018
Panic disorder is characterised by repeated, unexpected panic attacks, which represent a discrete period of fear or anxiety that has a rapid onset, reaches a peak within 10 minutes, and in which at least four of 13 characteristic symptoms are experienced,
- Antidepressants versus placebo for people with bulimia nervosa
Cochrane Systematic Reviews, 20-Oct-2003
Bulimia Nervosa (BN) represents an important public health problem and is related to serious morbidity and even mortality. This review attempted to systematically evaluate the use of antidepressant medications compared with placebo for the treatment of bu
- Antidepressants versus placebo for the depressed elderly
Cochrane Systematic Reviews, 22-Jan-2001
Depression warranting intervention is found in ten percent of people over the age of 60. Older depressed people are more likely to die than non-depressed. Relatively few receive therapeutic interventions, and those that do, tend to receive low dose antide
- Antidepressants versus psychological treatments and their combination for bulimia nervosa
Cochrane Systematic Reviews, 23-Oct-2001
Psychotherapeutic approaches, mainly cognitive behavior therapy, and antidepressant medication are the two treatment modalities that have received most support in controlled outcome studies of bulimia nervosa.
- Antidotes for acute cardenolide (cardiac glycoside) poisoning
Cochrane Systematic Reviews, 12-Oct-2008
Cardenolides are naturally occurring plant toxins which act primarily on the heart. While poisoning with the digitalis cardenolides (digoxin and digitoxin) are reported worldwide, cardiotoxicity from other cardenolides such as the yellow oleander are also
- Antiemetic medication for prevention and treatment of chemotherapy‐induced nausea and vomiting in childhood
Cochrane Systematic Reviews, 2-Feb-2016
Nausea and vomiting remain a problem for children undergoing treatment for malignancies despite new antiemetic therapies. Optimising antiemetic regimens could improve quality of life by reducing nausea, vomiting, and associated clinical problems. This is
- Antiemetics for adults for prevention of nausea and vomiting caused by moderately or highly emetogenic chemotherapy: a network meta‐analysis
Cochrane Systematic Reviews, 16-Nov-2021
About 70% to 80% of adults with cancer experience chemotherapy-induced nausea and vomiting (CINV). CINV remains one of the most distressing symptoms associated with cancer therapy and is associated with decreased adherence to chemotherapy. Combining 5-hyd
- Antiemetics for reducing vomiting related to acute gastroenteritis in children and adolescents
Cochrane Systematic Reviews, 7-Aug-2011
Vomiting is a common manifestation of acute gastroenteritis in children and adolescents. When untreated it can be a hindrance to oral rehydration therapy, which is the cornerstone in the management of acute gastroenteritis. Evidence is needed concerning t
